Honz Pharmaceutical Co., Ltd. (SHE:300086)
China flag China · Delayed Price · Currency is CNY
9.33
+0.06 (0.65%)
Feb 27, 2026, 3:04 PM CST

Honz Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
4,2462,2302,6422,7993,9062,529
Market Cap Growth
104.61%-15.57%-5.63%-28.34%54.45%6.84%
Enterprise Value
4,7392,6763,0333,1964,2512,952
Last Close Price
9.334.905.876.228.685.60
PE Ratio
--229.10-355.50270.79
Forward PE
-36.3236.3236.3236.3236.32
PS Ratio
9.754.723.575.224.672.74
PB Ratio
3.961.911.922.072.511.58
P/TBV Ratio
4.542.262.272.483.052.46
P/FCF Ratio
278.54-----
P/OCF Ratio
34.4331.2137.3795.45344.77-
EV/Sales Ratio
10.885.664.105.975.083.20
EV/EBITDA Ratio
--22.93-126.4825.22
EV/EBIT Ratio
--55.30--44.10
EV/FCF Ratio
310.83-----
Debt / Equity Ratio
0.450.440.360.430.380.39
Debt / EBITDA Ratio
--3.79-15.095.31
Debt / FCF Ratio
31.90-----
Net Debt / Equity Ratio
0.440.340.260.230.220.23
Net Debt / EBITDA Ratio
-6.43-4.222.70-3.259.933.10
Net Debt / FCF Ratio
30.72-18.87-5.33-10.58-1.60-1.15
Asset Turnover
0.220.230.330.230.330.38
Inventory Turnover
1.071.061.471.462.052.38
Quick Ratio
0.210.420.850.790.990.76
Current Ratio
0.670.891.601.331.491.22
Return on Equity (ROE)
-16.80%-17.65%0.38%-13.61%0.67%1.25%
Return on Assets (ROA)
-3.92%-4.73%1.54%-3.86%-0.13%1.74%
Return on Invested Capital (ROIC)
-8.10%-9.51%0.71%-8.25%-0.14%2.57%
Return on Capital Employed (ROCE)
-8.80%-10.60%3.10%-8.20%-0.30%3.30%
Earnings Yield
-4.48%-9.70%0.44%-6.70%0.28%0.37%
FCF Yield
0.36%-0.94%-2.53%-1.06%-5.34%-12.51%
Dividend Yield
-----0.36%
Payout Ratio
--211.14%-370.22%241.72%
Buyback Yield / Dilution
-0.58%-1.34%-0.10%0.08%-0.29%0.23%
Total Shareholder Return
-0.58%-1.34%-0.10%0.08%-0.29%0.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.